“It’s pretty wild right now,” said Jonathan Medved, founder and CEO of Israel-based OurCrowd, a platform with about 20 different cyber investments in that country, such as BioCatch, ThetaRay and Cymptom.
Read more here.
“It’s pretty wild right now,” said Jonathan Medved, founder and CEO of Israel-based OurCrowd, a platform with about 20 different cyber investments in that country, such as BioCatch, ThetaRay and Cymptom.
Read more here.